Five Health Technology Finalists Compete to Advance Cardiovascular and Brain Health Solutions

The American Heart Association has named five finalists in its 8th annual Health Tech Competition, hosted by the Center for Health Technology & Innovation, addressing the critical gap between healthcare innovation and adoption for heart disease and stroke, the world's leading causes of death. The competition provides a live forum for companies to present technologies designed to prevent or treat cardiovascular conditions including high blood pressure, stroke, heart failure and related disorders.

This year's finalists represent cutting-edge approaches to cardiovascular and neurological health. Brainomix, based in Oxford, England, is creating AI-powered software to improve stroke diagnosis and treatment decisions. Cambrian Health from San Francisco is building an AI-powered platform that ensures clinical best practices are seamlessly executed at the point of care. Boston-based Lumia delivers wearable solutions for people with orthostatic intolerance and chronic blood flow disorders.

European innovation is represented by Berlin's Noah Labs, which transforms voice into a digital biomarker to enable earlier intervention for cardiometabolic diseases. From Houston, Texas, PolyVascular is developing minimally invasive solutions for children with congenital heart disease, aiming to reduce the need for repeated open-heart surgeries. These companies will present their solutions in the Health Innovation Pavilion during Scientific Sessions 2025, the American Heart Association's flagship global event for cardiovascular science advancements.

The final presentations will be delivered live at the New Orleans Ernest N. Morial Convention Center on November 8-9, 2025, from 11:30 a.m. to 1 p.m. CT. A distinguished panel of expert volunteer judges will evaluate presentations based on three key criteria: validity of the working prototype or product in the market, scientific rigor of validation research using evidence-based health research, and impact on improving patient outcomes through innovative technology.

The judging panel includes prominent figures from medicine, venture capital, and healthcare innovation such as Eric D. Peterson, M.D., M.P.H., FAHA, professor of medicine at UT Southwestern Medical Center; Lee Shapiro, J.D., volunteer chairman of the American Heart Association board; and Lisa Suennen, managing partner at American Heart Association Ventures. Additional judges include representatives from medical technology investment funds, academic institutions, and clinical practice.

The competition winner will receive complimentary membership in the Center for Health Technology & Innovation Innovators' Network, a consortium connecting entrepreneurs, providers, researchers and payers to advance cardiovascular and brain health innovation. This membership provides significant advantages, including collaboration opportunities for building clinical outcome study models that lower development costs, connecting science to technology, and providing evidence that digital platforms improve healthcare outcomes.

Robert A. Harrington, M.D., FAHA, volunteer past president of the American Heart Association and volunteer chair of the Association's Health Tech Advisory Group, emphasized that "The Center for Health Technology & Innovation aims to advance the rapid, efficient and effective development of health care technology. Joining the Innovators' Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena."

Innovators' Network members also gain access to the American Heart Association's digital evidence-based scientific guidelines and clinical recommendations as they develop digital healthcare technologies. More information about the Health Tech competition is available at https://ahahealthtech.org/aha-health-tech-competition-2025. The Association maintains strict policies to prevent corporate donations from influencing its science content and policy positions, with more than 85% of revenue coming from non-corporate sources including individual contributions, foundations, and investment earnings.